Firms
Bristol Myers Squibb
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture PartnersDispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23Arsenal Biosciences$325M · 2024-09-04
ArsenalBio$325M · 2024-09-04
Autobahn$100M · 2024-07-23
Autobahn Therapeutics$100M · 2024-07-23Arsenal Biosciences$325M · 2024
HiberCell$67M · 2021-05-19
Autobahn Therapeutics$76M · 2020-06-09
Alexandria Venture InvestmentsDispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23
Autobahn Therapeutics$76M · 2020-06-09
Canaan Partners
Autobahn$100M · 2024-07-23
Autobahn Therapeutics$100M · 2024-07-23
Hitachi Ventures
ArsenalBio$325M · 2024-09-04Arsenal Biosciences$325M · 2024
Insight Partners
Autobahn$100M · 2024-07-23
Autobahn Therapeutics$100M · 2024-07-23
Kleiner Perkins
ArsenalBio$325M · 2024-09-04Arsenal Biosciences$325M · 2024
Magnetic Ventures
Transition Bio$50M · 2022-06-02
HiberCell$67M · 2021-05-19
Monograph Capital
Autobahn$100M · 2024-07-23
Autobahn Therapeutics$100M · 2024-07-23
Newpath Partners
Autobahn$100M · 2024-07-23
Autobahn Therapeutics$100M · 2024-07-23
Stanford University
Dispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23
Westlake BioPartners
ArsenalBio$325M · 2024-09-04Arsenal Biosciences$325M · 2024
AstraZeneca
Asher Bio$55M · 2024
Boxer Capital
Asher Bio$55M · 2024
BVF Partners L.P.
Autobahn Therapeutics$76M · 2020-06-09
Cambridge Enterprise
Transition Bio$50M · 2022-06-02
Cowen Healthcare Investments
Autobahn Therapeutics$76M · 2020-06-09
Hercules Capital, Inc.
HiberCell$67M · 2021-05-19
Lifeforce Capital
Transition Bio$50M · 2022-06-02
Luma Group
ArsenalBio$325M · 2024-09-04
Northpond Ventures
Transition Bio$50M · 2022-06-02
NVentures
ArsenalBio$325M · 2024-09-04
NVIDIA Corporation
Arsenal Biosciences$325M · 2024-09-04
Raptor Group
HiberCell$67M · 2021-05-19
Regeneron Pharmaceuticals
Arsenal Biosciences$325M · 2024-09-04
Samsara BioCapital
Autobahn Therapeutics$76M · 2020-06-09
Sixth Street Growth
Arsenal Biosciences$325M · 2024-09-04
T. Rowe Price
Arsenal Biosciences$325M · 2024
Taiho Ventures
Transition Bio$50M · 2022-06-02
Tekla Capital Management
HiberCell$67M · 2021-05-19
Third Rock Ventures
Asher Bio$55M · 2024
Wellington Management
Asher Bio$55M · 2024
Y Combinator
Asher Bio$55M · 2024